195 related articles for article (PubMed ID: 17932222)
1. Regulation of hepatic drug-metabolizing enzyme genes by Toll-like receptor 4 signaling is independent of Toll-interleukin 1 receptor domain-containing adaptor protein.
Ghose R; White D; Guo T; Vallejo J; Karpen SJ
Drug Metab Dispos; 2008 Jan; 36(1):95-101. PubMed ID: 17932222
[TBL] [Abstract][Full Text] [Related]
2. Differential role of Toll-interleukin 1 receptor domain-containing adaptor protein in Toll-like receptor 2-mediated regulation of gene expression of hepatic cytokines and drug-metabolizing enzymes.
Ghose R; Guo T; Vallejo JG; Gandhi A
Drug Metab Dispos; 2011 May; 39(5):874-81. PubMed ID: 21303924
[TBL] [Abstract][Full Text] [Related]
3. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
Shah P; Omoluabi O; Moorthy B; Ghose R
Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 4-phosphate 5-kinase α facilitates Toll-like receptor 4-mediated microglial inflammation through regulation of the Toll/interleukin-1 receptor domain-containing adaptor protein (TIRAP) location.
Nguyen TT; Kim YM; Kim TD; Le OT; Kim JJ; Kang HC; Hasegawa H; Kanaho Y; Jou I; Lee SY
J Biol Chem; 2013 Feb; 288(8):5645-59. PubMed ID: 23297396
[TBL] [Abstract][Full Text] [Related]
5. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism.
Scott MJ; Liu S; Shapiro RA; Vodovotz Y; Billiar TR
Hepatology; 2009 May; 49(5):1695-708. PubMed ID: 19296467
[TBL] [Abstract][Full Text] [Related]
6. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
Yamamoto M; Sato S; Hemmi H; Sanjo H; Uematsu S; Kaisho T; Hoshino K; Takeuchi O; Kobayashi M; Fujita T; Takeda K; Akira S
Nature; 2002 Nov; 420(6913):324-9. PubMed ID: 12447441
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
8. Rac1 and Toll-IL-1 receptor domain-containing adapter protein mediate Toll-like receptor 4 induction of HIV-long terminal repeat.
Equils O; Madak Z; Liu C; Michelsen KS; Bulut Y; Lu D
J Immunol; 2004 Jun; 172(12):7642-6. PubMed ID: 15187145
[TBL] [Abstract][Full Text] [Related]
9. Role of constitutive androstane receptor in Toll-like receptor-mediated regulation of gene expression of hepatic drug-metabolizing enzymes and transporters.
Shah P; Guo T; Moore DD; Ghose R
Drug Metab Dispos; 2014 Jan; 42(1):172-81. PubMed ID: 24194512
[TBL] [Abstract][Full Text] [Related]
10. Toll-Interleukin 1 Receptor domain-containing adaptor protein positively regulates BV2 cell M1 polarization.
Gong L; Wang H; Sun X; Liu C; Duan C; Cai R; Gu X; Zhu S
Eur J Neurosci; 2016 Jun; 43(12):1674-82. PubMed ID: 27061018
[TBL] [Abstract][Full Text] [Related]
11. Role of Toll-like receptor 4 in drug-drug interaction between paclitaxel and irinotecan in vitro.
Mallick P; Basu S; Moorthy B; Ghose R
Toxicol In Vitro; 2017 Jun; 41():75-82. PubMed ID: 28242239
[TBL] [Abstract][Full Text] [Related]
12. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP.
Andreakos E; Sacre SM; Smith C; Lundberg A; Kiriakidis S; Stonehouse T; Monaco C; Feldmann M; Foxwell BM
Blood; 2004 Mar; 103(6):2229-37. PubMed ID: 14630816
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-4 regulation of hepatic Cyp3a11 metabolism in a mouse model of LPS-induced CNS inflammation.
Goralski KB; Abdulla D; Sinal CJ; Arsenault A; Renton KW
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G434-43. PubMed ID: 15878984
[TBL] [Abstract][Full Text] [Related]
14. Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.
Gandhi A; Guo T; Shah P; Moorthy B; Ghose R
Toxicol Appl Pharmacol; 2013 Feb; 266(3):430-8. PubMed ID: 23238562
[TBL] [Abstract][Full Text] [Related]
15. Hepatic preconditioning using lipopolysaccharide: association with specific negative regulators of the Toll-like receptor 4 signaling pathway.
Sano T; Izuishi K; Hossain MA; Inoue T; Kakinoki K; Hagiike M; Okano K; Masaki T; Suzuki Y
Transplantation; 2011 May; 91(10):1082-9. PubMed ID: 21403587
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide-induced down-regulation of organic anion transporting polypeptide 4 (Oatp4; Slc21a10) is independent of tumor necrosis factor-alpha, Interleukin-1beta, interleukin-6, or inducible nitric oxide synthase.
Li N; Klaassen CD
Toxicol Sci; 2005 Jan; 83(1):197-203. PubMed ID: 15483191
[TBL] [Abstract][Full Text] [Related]
17. [TIR domain--containing adaptors regulate TLR-mediated signaling pathways].
Yamamoto M; Akira S
Nihon Rinsho; 2004 Dec; 62(12):2197-203. PubMed ID: 15597785
[TBL] [Abstract][Full Text] [Related]
18. Targeting Toll-like receptor (TLR) signaling by Toll/interleukin-1 receptor (TIR) domain-containing adapter protein/MyD88 adapter-like (TIRAP/Mal)-derived decoy peptides.
Couture LA; Piao W; Ru LW; Vogel SN; Toshchakov VY
J Biol Chem; 2012 Jul; 287(29):24641-8. PubMed ID: 22648407
[TBL] [Abstract][Full Text] [Related]
19. Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways.
Dong JW; Vallejo JG; Tzeng HP; Thomas JA; Mann DL
Am J Physiol Heart Circ Physiol; 2010 Mar; 298(3):H1079-87. PubMed ID: 20061547
[TBL] [Abstract][Full Text] [Related]
20. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.
Mitchell J; Kim SJ; Seelmann A; Veit B; Shepard B; Im E; Rhee SH
Biochem Pharmacol; 2018 Jan; 147():119-127. PubMed ID: 29175418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
